Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer
about
Metastasis suppressor genesMetastasis suppressor genes at the interface between the environment and tumor cell growthCK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.Modelling and simulation of mutant alleles of breast cancer metastasis suppressor 1 (BRMS1) geneCombined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cellsInhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells.Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.Genomics screens for metastasis genesLow BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survivalHomotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibitionMetastasis suppressors and the tumor microenvironmentUnraveling the enigmatic complexities of BRMS1-mediated metastasis suppressionBreast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancerCommunication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expressionBreast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expressionLinking metastasis suppression with metastamiR regulation.Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma.Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes.The role of TWIST1 in epithelial-mesenchymal transition and cancers.BRMS1 regulates apoptosis in non-small cell lung cancer cells.Effect of BRMS1 on tumorigenicity and metastasis of human rectal cancer.Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expressionBRMS1 gene expression may be associated with clinico-pathological features of breast cancer.Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma via regulation of BRMS1.
P2860
Q26866948-70C6F0BE-E1E3-42C8-A707-3AD2F8227DC6Q28394526-D2AF1A32-210A-4310-AE31-1B887FA971A1Q30277146-CDA7E79A-295E-4143-A506-4521EAC26399Q30301313-2D5174E7-5AEA-4AE1-B394-2EEAB24EC461Q30366409-A4CDE5BA-F040-4C88-86B5-6ED2C722DB8FQ30409676-C884C11A-019D-4F26-A489-88F0AFC1B0DFQ30413635-D5E4831A-92CE-4AE5-9A05-BBB1793B92A5Q30414771-F95DF0CC-A3FB-49DB-A17A-FBED1D87257DQ30425294-1F8CC748-801A-4B94-87F9-334B8131DFCAQ30434853-3C326B57-6DEA-4C5E-96EB-E735AC0DC45BQ33483295-5676CEC8-3275-4D16-972B-1A0D97CEE3D7Q33690185-28A43E6F-8BBE-43E0-9A68-88DFCBCD506BQ33865732-23F6A47D-E9DA-49F0-91E1-CA4C7282CC14Q34166924-54ED6CF1-0183-446A-A70B-52C3F9CD6B84Q34298860-3B0BEC5F-E79A-41B6-817D-7FE7C2AAAC0CQ34397133-231032EB-82B7-40D4-8526-4AC50AFD8FEFQ34412950-2B5A12BF-D23E-4240-919B-AE11E83C4F4AQ34648929-F0CE14B8-010F-4028-A41C-459FB757F9B1Q35374953-89E3FAC0-7144-4DBC-9ADB-5076C10D83F9Q35828437-FABA0D26-619C-4A0B-8E89-6C1CDAB4C000Q36261630-C04D50C3-ED33-4984-8DA2-293B612914D8Q36386459-670295E7-B9AC-44CD-9EC7-A00A0ACA7BCAQ36642559-E986544B-1070-4A7A-B299-BFEDEDF5868BQ36781251-874AEE17-2FDE-41C8-8ED5-970A4FE76C6BQ36865586-60DC67AA-8161-4EA2-8005-45D942263CE8Q37077434-9AC0F81C-6D8D-4448-B297-454C643DFA45Q37269104-2C4E83A4-3F14-41F7-82D9-B7BD762C8384Q37359847-53198573-4576-4E20-834F-7B55817AF8BCQ37377799-574276DF-CBEC-4893-8961-67D24213FC23Q37412910-23197B6A-557E-406A-A716-2613BDBAD8C2Q37711629-E5B98A6F-C812-4114-9185-08B879D16129Q38017096-D2BA7434-C4D7-4F66-B1DC-C060DB749C1BQ38646345-535EC947-3B8D-4048-AA73-6B36CC374686Q38960429-2F83464A-22DA-43D6-8941-A55CDBA81AA2Q39002658-90F0D8E2-6458-48D6-8613-8A805D68DF52Q39289574-7AF93173-1137-40D9-A007-564F969D161AQ40202794-BBB97DC1-E622-48F6-8E16-2F60712F30F9Q40256293-6906F44B-2A57-47FC-B904-CE35DAFA069EQ45885614-09065BE5-186D-4A76-B6F6-9BDBF1283A46Q47220717-EB6E4C93-5E98-419D-92F2-DE7110E553E9
P2860
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Breast cancer metastasis suppr ...... in non-small cell lung cancer
@ast
Breast cancer metastasis suppr ...... in non-small cell lung cancer
@en
type
label
Breast cancer metastasis suppr ...... in non-small cell lung cancer
@ast
Breast cancer metastasis suppr ...... in non-small cell lung cancer
@en
prefLabel
Breast cancer metastasis suppr ...... in non-small cell lung cancer
@ast
Breast cancer metastasis suppr ...... in non-small cell lung cancer
@en
P2093
P2860
P1433
P1476
Breast cancer metastasis suppr ...... in non-small cell lung cancer
@en
P2093
David R Jones
Gina R Petroni
Philip W Smith
Suzanne A Siefert
P2860
P304
P356
10.1016/J.CANLET.2008.11.024
P407
P577
2008-12-25T00:00:00Z